Member Info for ManiMaker

i saw this at 128-9 this morning but dint buy as i thought well its only worth 130p so no point. but its gone over 130p, how does that work??

("AdEPT Telecom" or the "Company") Director Dealing The Company has been advised that on 18 February 2011, Dusko Lukic, Non-Executive Director, acquired 25,000 ordinary shares of 10p each ("Ordinary Shares") in the Company, at 35p per share. On 21 February 2011, Dusko Lukic acquired a further 25,000 Ordinary Shares at 40p per share. Following this purchase, Mr Lukic has a total beneficial interest in 92,500 Ordinary Shares, representing approximately 0.44% of the current issued share capital of the Company. For further information on AdEPT Telecom please visit www.adept-telecom.co.uk or contact:

21/02/11

from here then..? when is news due guys?

wher is every1? :)

traders are a nervous lot with itchy fingers over the sell button. should hold it and then come back to see a nice rise. if u wanna make 10p profit dont waste ur time, just ask me for it. saves on the trading fees :) make sum real profit..wen this rises to 1p ul be onto a multibagger and treble ur money. HOLD

.

buying pressure must be on. Lets see 0.72 today :)

would like to see .7 again today i reckon these spike lock people in and therl be sum from last week who are selling out. but if they buy into the company rather that just trade it then itll be sustained rises longterm over 1p for sure

ready for big push now

approx 5mins...chance to topup if u bought at 0.54p average down..

could dip again, dont sell!! hold on cuz its just a shake. hardly any1 on different BB's know abt it here..spread the word!

sorry meant to put a full stop. i mean thats wat we'l break if buying pressure continues today. hold for higher profits..

.71 buys flying in

treeshake?

mine was the 5000k buy..ahh its a beautiful day :)

feel for you...sold out wrong time?

steady rise is better, dont wanna pump and dump. any1 seen SAR, might be worth a look, RNS released today. SAREUM HOLDINGS PLC ("Sareum" or the "Company") Research Update: Positive Leukaemia Model Study Sareum (AIM: SAR), the specialist cancer drug discovery business, is pleased to announce positive results from its pre-clinical in-vivo efficacy studies into acute myeloid leukaemia (AML), the most common form of adult leukaemia.

equivalent to the rest of te whole days trades that are showing above. im sure there are other trades that havnt shown here but mey do on other levels

erm thnx for that Danny, i look forward to it lol